BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Dec. 16, 2009

View Archived Issues

Panel recommends RCTs for prostate cancer treatments

GAITHERSBURG, Maryland – As some device makers tell it, enrolling patients into a randomized clinical trial (RCT) is like getting dancers on the dance floor, at least in one respect; it's tough to get someone to be the first. Unlike the accumulation of dancers on the dance floor, however, the arrival of the first enrollee in an RCT does not ensure a landslide of participation. (Medical Device Daily) Read More

ConforMIS launches next generation iUni G2 device

Read More

Report from Europe: Alcon bolsters ophthalmology segment with Optonol purchase

Read More

Court report: Luna settles with Hansen, gives up stock, $5M promissory note

Read More

Deals roundup: Covidien says $58.7M tender offer accepted by Aspect

Read More

Coming Wednesday in MDD Perspectives: The "war" on Christmas: Three lessons, no carols

Read More

Financings roundup: SBi secures $30M credit facility, funds support new products

Read More

Agreements/contracts: Corgenix, BG Medicine form supply agreement

Read More

Patent watch: Sword Diagnostics secures Raman Scattering test tech

Read More

Med-Tech Notes

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Cardio Extra

Read More

New blood test may detect early-stage colon cancer

Medical researchers with EDP Biotech (Knoxville, Tennessee) say they have captured national attention with a new technology for a simple blood test designed to detect early-stage colon cancer. (Medical Device Daily) Read More

Myomo restores function in stroke patient victims

Read More

Report from Europe: Ability of cardiopoietic cells to restore cardiac function evaluated

Read More

Washington roundup: Device tax would be delayed under new Senate amendment

Read More

Deals roundup: Abbott to acquire Starlims Technologies for $123M in cash

Read More

Today's MDD food for med-tech thought

Read More

Agreements/contracts: HealthEdge partners with iWay to integrate HealthRules

Read More

Patent watch: ATS Medical gains tech to cut tissue materials for devices

Read More

Financings roundup: PatientKeeper raises $13M to help attain 'meaningful use'

Read More

Court report: 30 indicted for $61 million in fraudulent Medicare billings

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Oncology Extra

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

    BioWorld Science
    Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
  • Wuxi Apptec signage

    Wuxi Apptec insists it’s ‘not a Chinese military company’

    BioWorld
    Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing